Haijun ChenMedical Affairs Department of BeiGene (Beijing) Co. Ltd关注立即认领分享关注立即认领分享基本信息浏览量:0职业迁徙个人简介暂无内容研究兴趣论文共 2 篇作者统计合作学者相似作者按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选时间引用量主题期刊级别合作者合作机构The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysisWenwu He,Chenghao Wang,Changding Li,Xin Nie,Haojun Li,Jialong Li, Na Zhao,Haijun Chen, Xiaojie Miao,Yongtao Han,Lin Peng,Xuefeng LengFrontiers in Immunology (2023): 1118902-1118902引用0浏览0WOS引用00Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory StudyWenwu He,Chenghao Wang,Lei Wu,Gang Wan,Baisen Li,Yongtao Han,Haojun Li,Xuefeng Leng,Kunyi Du,Haijun Chen,Qifeng Wang,Lin PengFRONTIERS IN IMMUNOLOGY(2022)引用8浏览0WOS引用80作者统计合作学者合作机构D-Core合作者学生导师暂无相似学者,你可以通过学者研究领域进行搜索筛选数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn